Oxbridge Re Holdings Ltd. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on August 28, 2025, regarding Oxbridge Re Holdings Ltd. (the "Company"), a Cayman Islands-based reinsurance holding company. The filing details the results of an Extraordinary General Meeting of Shareholders and the execution of new executive compensation and corporate governance agreements.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document focuses on corporate actions and equity structure changes rather than operational financial results.
Material Changes and Corporate Actions
- Authorized Share Capital Increase: Shareholders approved an amendment to the Memorandum and Articles of Association, increasing authorized share capital from 50,000,000 shares to 500,000,000 shares (an increase of 450,000,000 shares). The par value remains $0.001 per share.
- 2025 Omnibus Incentive Plan: Shareholders approved a new equity incentive plan reserving 1,569,514 ordinary shares for issuance. The plan includes an annual increase mechanism starting in fiscal year 2026, equal to the lesser of 5% of outstanding shares or a Board-determined amount.
- Executive Employment Agreements:
- Jay Madhu (CEO): Amended agreement effective Jan 1, 2026, with a base salary of $390,000. Includes annual grants of 40,000 restricted shares and a potential M&A transaction bonus of 6.3% of transaction value.
- Wrendon Timothy (CFO): Amended agreement effective Jan 1, 2026, with a base salary of $245,000. Includes annual grants of 25,000 restricted shares and a potential M&A transaction bonus of 2.7% of transaction value.
- Severance: Both executives are entitled to a three-year lump-sum base salary payment upon termination "without cause" or for "good reason."
- Anti-Takeover Measures: The Board approved "Corporate Action, Change of Control, and Performance Agreements" with the CEO and CFO. These agreements provide for fully vested Restricted Share Units (RSUs) upon a Change of Control or Corporate Transaction occurring on or prior to December 31, 2026, or upon achieving specific revenue milestones.
Shareholder Vote Results
As of the record date (August 7, 2025), there were 7,535,922 ordinary shares outstanding. Voting results were as follows:
| Proposal | For | Against | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| 1. Increase Authorized Share Capital | 3,962,636 | 937,088 | 10,180 | - |
| 2. Amend & Restate Articles of Association | 4,026,747 | 872,977 | 10,180 | - |
| 3. Approve 2025 Omnibus Incentive Plan | 2,208,088 | 501,887 | 56,823 | 2,143,106 |
Outlook, Risks, and Contingencies
- Hostile Takeover Vulnerability: The Board explicitly stated the Company is vulnerable to hostile takeover actions due to the lack of a shareholder rights plan and low management share ownership. The new performance agreements serve as a defensive measure.
- Performance Milestones: Future equity issuance to executives is contingent on achieving revenue milestones measured on specific dates through December 31, 2026.
- Financing Triggers: Executive base salaries are subject to automatic increases if the Company completes a financing or strategic transaction exceeding $100 million.
Key Facts for Investor Verification
- Verify the dilution impact of the 450,000,000 newly authorized shares and the 1,569,514 shares reserved for the new incentive plan.
- Review the specific definitions of "Revenue Milestones" and "Change of Control" in the attached agreements (Exhibits 10.5 and 10.6) to understand the potential for accelerated equity vesting.
- Assess the financial impact of the new executive compensation structure, particularly the M&A transaction bonuses (6.3% for CEO, 2.7% for CFO) and three-year severance liabilities.
- Confirm the Company's current cash position and ability to fund the increased authorized capital if shares are issued.